Drugmaker Indivior's finance chief Preblick to step downDec 17 (Reuters) - Indivior INDV.L said on Tuesday its finance chief Ryan Preblick will step down as the British drugmaker makes changes to its board following pressure from no.2 shareholder Oaktree Capital.
The maker of opioid addiction treatment Sublocade also appointed Robert Schriesheim and Joe Ciaffoni as independent non-executive directors, and said it has agreed to move towards a more standard U.S. system of remuneration for directors following its recent primary listing in New York.
(Reporting by Yadarisa Shabong in Bengaluru; Editing by Sherry Jacob-Phillips)
((Yadarisa.Shabong@thomsonreuters.com; +91 9742735150;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments